important topics from the mpn congress 2024: addressing the risk of transformation to acute leukemia
Published 2 weeks ago • 134 plays • Length 9:34Download video MP4
Download video MP3
Similar videos
-
8:40
investigating pp2a-based therapeutic strategies for kmt2a-rearranged acute leukemia
-
2:11
the management of post-mpn aml
-
2:13
the future of mpn treatment: exciting agents and targets being investigated
-
0:37
factors that are important to consider when selecting patients with mpn for sct
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
2:45
an insight into clinical risk factors for progression in mpns
-
1:47
the role of ngs in improving diagnosis in mpns
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
1:35:53
clinical trial updates
-
1:14:30
national action plan: how it will help australians with blood cancer
-
1:30
recent advancements in bpdcn: diagnostic criteria, pathophysiology, and treatment
-
1:39
next questions in the treatment and management of mpns
-
0:57
novel therapeutic strategies in all
-
1:52
the importance of symptom management in mpns
-
0:50
management of variant acute promyelocytic leukemia
-
2:42
hot topics in mpns: disease-modifying drugs, sequencing jak inhibitors and management of bp-mpns
-
2:52
novel prognostic score for cmml patients undergoing sct
-
1:58
mpn advances day 2019: highlights
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:28
key topics at ish 2022
-
2:22
development of novel menin-mll inhibitors for acute leukemias